USNA
USANA Health Sciences, Inc.
Price Chart
Latest Quote
$18.61
-0.41 (-2.16%)
Current Price
| Previous Close | $19.02 |
| Open | $19.01 |
| Day High | $19.47 |
| Day Low | $18.27 |
| Volume | 103,190 |
Stock Information
| Shares Outstanding | 18.46M |
| Total Debt | $14.00M |
| Cash Equivalents | $162.75M |
| Revenue | $925.94M |
| Net Income | $8.87M |
| Sector | Consumer Defensive |
| Industry | Packaged Foods |
| Market Cap | $343.69M |
| P/E Ratio | 37.23 |
| EPS (TTM) | $0.50 |
| Exchange | NYQ |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $253.47M |
| Sales | $925.94M |
| Income | $8.87M |
| Book/sh | $29.45 |
| Cash/sh | $8.81 |
| Employees | 2K |
Financial Ratios
| Quick Ratio | 1.47 |
| Current Ratio | 2.51 |
| Debt/Eq | 2.35 |
| EPS Growth TTM | -20.10% |
Returns & Margins
| ROA | 4.13% |
| ROE | 1.55% |
| Gross Margin | 77.55% |
| Operating Margin | 5.54% |
| Profit Margin | 0.96% |
Ownership
| Insider Ownership | 40.86% |
| Institutional Ownership | 56.60% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 6.72 |
| PEG | 0.81 |
| P/S | 0.37 |
| P/B | 0.63 |
Analyst Data
| Recommendation | none |
| Target Price | $39.00 |
Technical Indicators
| SMA20 | $18.67 |
| SMA50 | $18.74 |
| SMA200 | $20.87 |
| RSI | 47.91 |
| ATR | 0.7894 |
| Shares Float | 9.86M |
| Short Float | 5.87% |
| Short Ratio | 5.40 |
| Volatility | 0.77 |
| Rel Volume | 0.93 |
Performance History
| Week | -2.90% |
| Month | +3.19% |
| Quarter | +8.92% |
| 6 Months | -8.39% |
| YTD | -4.24% |
| Year | -39.66% |
| 3 Years | -70.21% |
| 5 Years | -82.11% |
| 10 Years | -66.89% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-17 | $18.61 | 103,192 |
| 2026-06-16 | $19.01 | 89,300 |
| 2026-06-15 | $19.41 | 153,300 |
| 2026-06-12 | $19.91 | 86,900 |
| 2026-06-11 | $19.87 | 123,600 |
| 2026-06-10 | $19.17 | 101,300 |
| 2026-06-09 | $19.01 | 112,500 |
| 2026-06-08 | $18.70 | 95,900 |
| 2026-06-05 | $18.03 | 86,000 |
| 2026-06-04 | $18.13 | 124,900 |
| 2026-06-03 | $17.46 | 103,700 |
| 2026-06-02 | $18.05 | 97,900 |
| 2026-06-01 | $18.33 | 135,500 |
| 2026-05-29 | $18.30 | 86,800 |
| 2026-05-28 | $18.84 | 107,100 |
| 2026-05-27 | $18.80 | 115,500 |
| 2026-05-26 | $18.26 | 135,200 |
| 2026-05-22 | $18.74 | 93,300 |
| 2026-05-21 | $18.56 | 144,700 |
| 2026-05-20 | $18.14 | 124,100 |
| 2026-05-19 | $17.47 | 115,400 |
| 2026-05-18 | $18.04 | 97,800 |
About USANA Health Sciences, Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
đ° Latest News
Zacks.com featured highlights include StoneCo, USANA Health, Strategic Education, Nexa Resources and CVS
Zacks âĸ 2026-06-15T07:39:00Z
5 Low Price-to-Book Stocks That Are Worth Buying in June
Zacks âĸ 2026-06-12T13:49:00Z
These 4 Low Price-to-Cash Flow Stocks Have Winning Potential
Zacks âĸ 2026-06-11T12:36:00Z
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now?
Zacks âĸ 2026-06-10T13:40:05Z
3 of Wall Streetâs Favorite Stocks We Steer Clear Of
StockStory âĸ 2026-06-08T10:21:50Z
3 Profitable Stocks with Open Questions
StockStory âĸ 2026-06-04T17:25:30Z
1 Stock Under $50 with Promising Prospects and 2 We Brush Off
StockStory âĸ 2026-06-01T17:12:51Z
Should Value Investors Buy USANA Health Sciences (USNA) Stock?
Zacks âĸ 2026-05-25T13:40:04Z
4 Top Value Stocks to Buy Now as Wall Street Takes Fresh Notice
Zacks âĸ 2026-05-22T13:50:00Z
5 Revealing Analyst Questions From USANAâs Q1 Earnings Call
StockStory âĸ 2026-05-15T06:28:55Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $200,852,000 | $161,212,000 | $176,693,000 | $193,890,000 |
| Cost Of Revenue | $200,852,000 | $161,212,000 | $176,693,000 | $193,890,000 |
| Total Revenue | $925,257,000 | $854,503,000 | $921,010,000 | $998,601,000 |
| Operating Revenue | $925,257,000 | $854,503,000 | $921,010,000 | $998,601,000 |
| Expenses | ||||
| Interest Expense | $842,000 | $281,000 | $262,000 | $192,000 |
| Total Expenses | $874,395,000 | $788,179,000 | $827,939,000 | $890,987,000 |
| Other Income Expense | $-10,908,000 | $-1,011,000 | $7,000 | $-2,590,000 |
| Other Non Operating Income Expenses | $2,522,000 | $-1,011,000 | $7,000 | $-2,590,000 |
| Net Non Operating Interest Income Expense | $1,573,000 | $11,038,000 | $9,375,000 | $3,597,000 |
| Interest Expense Non Operating | $842,000 | $281,000 | $262,000 | $192,000 |
| Operating Expense | $673,543,000 | $626,967,000 | $651,246,000 | $697,097,000 |
| Other Operating Expenses | $336,171,000 | $363,699,000 | $394,257,000 | $434,793,000 |
| General And Administrative Expense | $337,372,000 | $263,268,000 | $256,989,000 | $262,304,000 |
| Selling And Marketing Expense | - | - | $394,257,000 | $434,793,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $10,760,000 | $42,030,000 | $63,788,000 | $69,350,000 |
| Net Interest Income | $1,573,000 | $11,038,000 | $9,375,000 | $3,597,000 |
| Interest Income | $2,415,000 | $11,319,000 | $9,637,000 | $3,789,000 |
| Normalized Income | $18,818,000 | $42,030,000 | $63,788,000 | $69,350,000 |
| Net Income From Continuing And Discontinued Operation | $10,760,000 | $42,030,000 | $63,788,000 | $69,350,000 |
| Total Operating Income As Reported | $37,432,000 | $66,324,000 | $93,071,000 | $107,614,000 |
| Net Income Common Stockholders | $10,760,000 | $42,030,000 | $63,788,000 | $69,350,000 |
| Net Income | $10,760,000 | $42,030,000 | $63,788,000 | $69,350,000 |
| Net Income Including Noncontrolling Interests | $11,477,000 | $42,060,000 | $63,788,000 | $69,350,000 |
| Net Income Continuous Operations | $11,477,000 | $42,060,000 | $63,788,000 | $69,350,000 |
| Pretax Income | $41,527,000 | $76,351,000 | $102,453,000 | $108,621,000 |
| Special Income Charges | $-13,430,000 | - | - | - |
| Interest Income Non Operating | $2,415,000 | $11,319,000 | $9,637,000 | $3,789,000 |
| Operating Income | $50,862,000 | $66,324,000 | $93,071,000 | $107,614,000 |
| Gross Profit | $724,405,000 | $693,291,000 | $744,317,000 | $804,711,000 |
| Per Share | ||||
| Diluted EPS | $0.58 | $2.19 | $3.30 | $3.59 |
| Basic EPS | $0.59 | $2.21 | $3.33 | $3.61 |
| Other | ||||
| Tax Effect Of Unusual Items | $-5,372,000 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $95,501,000 | $98,861,000 | $123,110,000 | $130,223,000 |
| Total Unusual Items | $-13,430,000 | - | - | - |
| Total Unusual Items Excluding Goodwill | $-13,430,000 | - | - | - |
| Reconciled Depreciation | $39,702,000 | $22,229,000 | $20,395,000 | $21,410,000 |
| EBITDA (Bullshit earnings) | $82,071,000 | $98,861,000 | $123,110,000 | $130,223,000 |
| EBIT | $42,369,000 | $76,632,000 | $102,715,000 | $108,813,000 |
| Diluted Average Shares | $18,574,000 | $19,162,000 | $19,345,000 | $19,310,000 |
| Basic Average Shares | $18,280,857 | $19,064,000 | $19,130,000 | $19,206,000 |
| Diluted NI Availto Com Stockholders | $10,760,000 | $42,030,000 | $63,788,000 | $69,350,000 |
| Minority Interests | $-717,000 | $-30,000 | $0 | - |
| Tax Provision | $30,050,000 | $34,291,000 | $38,665,000 | $39,271,000 |
| Other Special Charges | $6,463,000 | - | - | - |
| Impairment Of Capital Assets | $6,967,000 | - | - | - |
| Selling General And Administration | $337,372,000 | $263,268,000 | $256,989,000 | $262,304,000 |
| Other Gand A | $337,372,000 | $263,268,000 | $256,989,000 | $262,304,000 |
Fetched: 2026-06-14
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $261,991,000 | $236,118,000 | $450,181,000 | $384,672,000 |
| Total Assets | $742,915,000 | $748,193,000 | $632,757,000 | $596,549,000 |
| Total Non Current Assets | $454,510,000 | $469,006,000 | $215,011,000 | $212,167,000 |
| Other Non Current Assets | $61,805,000 | $58,806,000 | $54,892,000 | $54,795,000 |
| Non Current Deferred Assets | $27,209,000 | $19,644,000 | $13,284,000 | $9,799,000 |
| Non Current Deferred Taxes Assets | $27,209,000 | $19,644,000 | $13,284,000 | $9,799,000 |
| Goodwill And Other Intangible Assets | $271,113,000 | $295,991,000 | $47,021,000 | $49,800,000 |
| Other Intangible Assets | $133,151,000 | $151,823,000 | $29,919,000 | $32,432,000 |
| Current Assets | $288,405,000 | $279,187,000 | $417,746,000 | $384,382,000 |
| Other Current Assets | $4,853,000 | $4,808,000 | $6,096,000 | $7,121,000 |
| Current Deferred Assets | $914,000 | $894,000 | $1,181,000 | $3,157,000 |
| Prepaid Assets | $12,545,000 | $13,759,000 | $11,394,000 | $11,382,000 |
| Inventory | $102,608,000 | $69,735,000 | $61,454,000 | $67,089,000 |
| Receivables | $9,105,000 | $8,223,000 | $7,201,000 | $7,213,000 |
| Other Receivables | $8,089,000 | $7,419,000 | $6,172,000 | $5,183,000 |
| Taxes Receivable | $1,016,000 | $804,000 | $1,029,000 | $2,030,000 |
| Cash Cash Equivalents And Short Term Investments | $158,380,000 | $181,768,000 | $330,420,000 | $288,420,000 |
| Cash And Cash Equivalents | $158,380,000 | $181,768,000 | $330,420,000 | $288,420,000 |
| Debt | ||||
| Total Debt | $19,650,000 | $29,013,000 | $8,064,000 | $6,892,000 |
| Current Debt And Capital Lease Obligation | $19,650,000 | $29,013,000 | $8,064,000 | $6,892,000 |
| Current Debt | $14,000,000 | $23,000,000 | $786,000 | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $156,643,000 | $161,861,000 | $135,555,000 | $162,077,000 |
| Total Non Current Liabilities Net Minority Interest | $28,078,000 | $22,236,000 | $16,710,000 | $18,244,000 |
| Other Non Current Liabilities | $23,186,000 | $18,163,000 | $12,158,000 | $14,173,000 |
| Non Current Deferred Liabilities | $4,892,000 | $4,073,000 | $4,552,000 | $4,071,000 |
| Non Current Deferred Taxes Liabilities | $4,892,000 | $4,073,000 | $4,552,000 | $4,071,000 |
| Current Liabilities | $128,565,000 | $139,625,000 | $118,845,000 | $143,833,000 |
| Other Current Liabilities | $39,548,000 | $45,414,000 | $48,325,000 | $71,476,000 |
| Current Deferred Liabilities | $10,640,000 | $12,050,000 | $13,910,000 | $20,875,000 |
| Payables And Accrued Expenses | $38,079,000 | $37,312,000 | $32,348,000 | $27,256,000 |
| Payables | $28,579,000 | $23,743,000 | $22,598,000 | $27,256,000 |
| Total Tax Payable | $11,316,000 | $11,759,000 | $12,528,000 | $16,207,000 |
| Income Tax Payable | $3,369,000 | $3,710,000 | $3,297,000 | $4,973,000 |
| Accounts Payable | $17,263,000 | $11,984,000 | $10,070,000 | $11,049,000 |
| Equity | ||||
| Common Stock Equity | $533,104,000 | $532,109,000 | $497,202,000 | $434,472,000 |
| Total Equity Gross Minority Interest | $586,272,000 | $586,332,000 | $497,202,000 | $434,472,000 |
| Stockholders Equity | $533,104,000 | $532,109,000 | $497,202,000 | $434,472,000 |
| Gains Losses Not Affecting Retained Earnings | $-16,178,000 | $-22,670,000 | $-13,695,000 | $-12,787,000 |
| Other Equity Adjustments | $-16,178,000 | $-22,670,000 | $-13,695,000 | $-12,787,000 |
| Retained Earnings | $465,720,000 | $478,944,000 | $445,217,000 | $391,636,000 |
| Other | ||||
| Ordinary Shares Number | $18,280,857 | $19,064,000 | $19,130,000 | $19,206,000 |
| Share Issued | $18,280,857 | $19,064,000 | $19,130,000 | $19,206,000 |
| Tangible Book Value | $261,991,000 | $236,118,000 | $450,181,000 | $384,672,000 |
| Invested Capital | $547,104,000 | $555,109,000 | $497,988,000 | $434,472,000 |
| Working Capital | $159,840,000 | $139,562,000 | $298,901,000 | $240,549,000 |
| Capital Lease Obligations | $5,650,000 | $6,013,000 | $7,278,000 | $6,892,000 |
| Total Capitalization | $533,104,000 | $532,109,000 | $497,202,000 | $434,472,000 |
| Minority Interest | $53,168,000 | $54,223,000 | $0 | - |
| Additional Paid In Capital | $83,544,000 | $75,816,000 | $65,661,000 | $55,604,000 |
| Capital Stock | $18,000 | $19,000 | $19,000 | $19,000 |
| Common Stock | $18,000 | $19,000 | $19,000 | $19,000 |
| Current Deferred Revenue | $10,640,000 | $12,050,000 | $13,910,000 | $20,875,000 |
| Current Capital Lease Obligation | $5,650,000 | $6,013,000 | $7,278,000 | $6,892,000 |
| Line Of Credit | $14,000,000 | $23,000,000 | $786,000 | $0 |
| Pensionand Other Post Retirement Benefit Plans Current | $20,648,000 | $15,836,000 | $16,198,000 | $17,334,000 |
| Current Accrued Expenses | $9,500,000 | $13,569,000 | $9,750,000 | - |
| Goodwill | $137,962,000 | $144,168,000 | $17,102,000 | $17,368,000 |
| Net PPE | $94,383,000 | $94,565,000 | $99,814,000 | $97,773,000 |
| Accumulated Depreciation | $-134,578,000 | $-130,088,000 | $-128,939,000 | $-124,748,000 |
| Gross PPE | $228,961,000 | $224,653,000 | $228,753,000 | $222,521,000 |
| Leases | $10,839,000 | $12,611,000 | $14,337,000 | $14,388,000 |
| Construction In Progress | $5,798,000 | $4,620,000 | $9,807,000 | $6,081,000 |
| Other Properties | $55,387,000 | $53,981,000 | $54,502,000 | $50,679,000 |
| Machinery Furniture Equipment | $68,428,000 | $67,183,000 | $62,321,000 | $63,308,000 |
| Buildings And Improvements | $78,585,000 | $76,677,000 | $77,803,000 | $78,071,000 |
| Land And Improvements | $9,924,000 | $9,581,000 | $9,983,000 | $9,994,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $65,873,000 | $41,663,000 | $36,899,000 | $41,028,000 |
| Work In Process | $5,003,000 | $3,612,000 | $4,707,000 | $4,285,000 |
| Raw Materials | $31,732,000 | $24,460,000 | $19,848,000 | $21,776,000 |
Fetched: 2026-06-14
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $8,526,000 | $50,919,000 | $56,147,000 | $93,502,000 |
| Operating Activities | ||||
| Operating Cash Flow | $22,349,000 | $60,992,000 | $70,641,000 | $103,902,000 |
| Cash Flow From Continuing Operating Activities | $22,349,000 | $60,992,000 | $70,641,000 | $103,902,000 |
| Operating Gains Losses | $-2,093,000 | $1,000 | $10,000 | $141,000 |
| Investing Activities | ||||
| Capital Expenditure | $-13,823,000 | $-10,073,000 | $-14,494,000 | $-10,400,000 |
| Investing Cash Flow | $-10,125,000 | $-213,090,000 | $-11,975,000 | $-12,370,000 |
| Cash Flow From Continuing Investing Activities | $-10,125,000 | $-213,090,000 | $-11,975,000 | $-12,370,000 |
| Net Other Investing Changes | - | - | - | - |
| Financing Activities | ||||
| Repurchase Of Capital Stock | $-27,507,000 | $-9,444,000 | $-11,599,000 | $-25,382,000 |
| Financing Cash Flow | $-40,603,000 | $9,553,000 | $-14,237,000 | $-30,088,000 |
| Cash Flow From Continuing Financing Activities | $-40,603,000 | $9,553,000 | $-14,237,000 | $-30,088,000 |
| Net Other Financing Charges | $-4,096,000 | $-3,223,000 | $-3,430,000 | $-4,706,000 |
| Net Common Stock Issuance | $-27,507,000 | $-9,444,000 | $-11,599,000 | $-25,382,000 |
| Other | ||||
| Repayment Of Debt | $-26,600,000 | $-1,467,000 | $-750,000 | $-11,000,000 |
| Issuance Of Debt | $17,600,000 | $23,687,000 | $1,542,000 | $11,000,000 |
| Interest Paid Supplemental Data | $663,000 | $76,000 | $68,000 | $49,000 |
| End Cash Position | $161,240,000 | $184,508,000 | $333,246,000 | $291,320,000 |
| Beginning Cash Position | $184,508,000 | $333,246,000 | $291,320,000 | $243,653,000 |
| Effect Of Exchange Rate Changes | $5,111,000 | $-6,193,000 | $-2,503,000 | $-13,777,000 |
| Changes In Cash | $-28,379,000 | $-142,545,000 | $44,429,000 | $61,444,000 |
| Common Stock Payments | $-27,507,000 | $-9,444,000 | $-11,599,000 | $-25,382,000 |
| Net Issuance Payments Of Debt | $-9,000,000 | $22,220,000 | $792,000 | $0 |
| Net Short Term Debt Issuance | $-9,000,000 | $22,220,000 | $792,000 | $0 |
| Short Term Debt Payments | $-26,600,000 | $-1,467,000 | $-750,000 | $-11,000,000 |
| Short Term Debt Issuance | $17,600,000 | $23,687,000 | $1,542,000 | $11,000,000 |
| Net Investment Purchase And Sale | $-1,072,000 | $255,000 | $2,504,000 | $4,555,000 |
| Sale Of Investment | $0 | $1,125,000 | $3,775,000 | $4,555,000 |
| Purchase Of Investment | $-1,072,000 | $-870,000 | $-1,271,000 | $0 |
| Net Business Purchase And Sale | $865,000 | $-203,336,000 | $0 | $-6,532,000 |
| Sale Of Business | $865,000 | $0 | $0 | - |
| Purchase Of Business | $0 | $-203,336,000 | $0 | $-6,532,000 |
| Net PPE Purchase And Sale | $-9,918,000 | $-10,009,000 | $-14,479,000 | $-10,393,000 |
| Sale Of PPE | $3,905,000 | $64,000 | $15,000 | $7,000 |
| Purchase Of PPE | $-13,823,000 | $-10,073,000 | $-14,494,000 | $-10,400,000 |
| Change In Working Capital | $-43,078,000 | $-13,003,000 | $-27,999,000 | $771,000 |
| Change In Other Current Liabilities | $-14,218,000 | $-6,745,000 | $-30,034,000 | $-9,066,000 |
| Change In Payables And Accrued Expense | $5,204,000 | $-1,269,000 | $-428,000 | $-2,656,000 |
| Change In Payable | $5,204,000 | $-1,269,000 | $-428,000 | $-2,656,000 |
| Change In Account Payable | $5,204,000 | $-1,269,000 | $-428,000 | $-2,656,000 |
| Change In Prepaid Assets | $621,000 | $-2,871,000 | $110,000 | $-3,304,000 |
| Change In Inventory | $-34,685,000 | $-2,118,000 | $2,353,000 | $15,797,000 |
| Stock Based Compensation | $13,828,000 | $14,558,000 | $14,595,000 | $13,331,000 |
| Asset Impairment Charge | $9,646,000 | $1,891,000 | $2,601,000 | $6,082,000 |
| Deferred Tax | $-7,133,000 | $-6,744,000 | $-2,749,000 | $-7,183,000 |
| Deferred Income Tax | $-7,133,000 | $-6,744,000 | $-2,749,000 | $-7,183,000 |
| Depreciation Amortization Depletion | $39,702,000 | $22,229,000 | $20,395,000 | $21,410,000 |
| Depreciation And Amortization | $39,702,000 | $22,229,000 | $20,395,000 | $21,410,000 |
| Depreciation | $39,702,000 | $22,229,000 | $20,395,000 | $21,410,000 |
| Gain Loss On Sale Of PPE | $-2,093,000 | $1,000 | $10,000 | $141,000 |
| Net Income From Continuing Operations | $11,477,000 | $42,060,000 | $63,788,000 | $69,350,000 |
| Income Tax Paid Supplemental Data | - | $40,470,000 | $44,247,000 | $45,863,000 |
Fetched: 2026-06-14